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Abstract
Introduction: The sensation of palpitations may either be the initial or the only symptom of cardiac arrhythmia.
We describe a case of an apparent clear temporal relationship between standard ibuprofen dosing and
palpitations. A review of the medical literature revealed this to be, to the best of our knowledge, the first reported
case of this type.
Case presentation: A 13-year-old Caucasian girl initially presented to our clinic with hamstring tendinitis. She was
commenced on a medication regimen of paracetamol and ibuprofen. After the third ibuprofen dose, she
experienced palpitations. These were associated with lower chest and/or upper abdominal discomfort, and a
feeling of being hot and sweaty. Her symptoms ceased upon the cessation of ibuprofen therapy.
Conclusion: Cardiac arrhythmia is a potentially fatal disorder that may exhibit heart palpitations as its initial (or
only) symptom. The prompt recognition of the cause of the symptom can reduce mortality and morbidity
associated with any underlying pathological processes. There is a need to investigate cases of recurrent palpitations
so as to exclude underlying structural cardiac pathology and/or abnormal cardiac rhythm.
Introduction
Tendinitis, or the inflammation of a tendon, is a muscu-
loskeletal disorder that is commonly seen in patients in
general practice clinics. It is usually treated with a com-
bination of rest, simple analgesics, a non-steroidal anti-
inflammatory drug (NSAID) and physical rehabilitation.
In this case report, we describe a case of cardiac palpita-
tions that temporally appears to be caused by standard
ibuprofen dosing, an event that has not been previously
described in the medical literature.
Case presentation
A 13-year-old Caucasian girl weighing 45 kg was exam-
ined in a general practice clinic with a short history of
left posterior thigh pain. There was no obvious precipi-
tant condition for her complaint. She reported no signif-
icant medical history, took no medications and had no
allergies. There was also no significant family medical
history. A clinical diagnosis of left hamstring tendinitis
was made. She was commenced on a regimen of
paracetamol 1 g qid prn, ibuprofen 400 mg tds, and a
gentle exercise and stretching program.
Shortly after taking the third 400 mg dose of ibupro-
fen, she felt hot and sweaty, and reported a sensation of
palpitations. There was associated lower chest and
upper abdominal discomfort, but she felt no frank chest
or abdominal pain. No other symptoms, in particularly
those suggestive of either an allergic reaction or an
acute coronary syndrome, were noted.
Our patient continued with ibuprofen treatment for
another day, with exacerbation of her symptoms after
each ibuprofen dose. After informing her mother of her
symptoms, her ibuprofen medication was discontinued.
Her symptoms ceased thereafter.
Upon clinical review a few days later, she was found
well with a pulse of 70. An electrocardiogram (ECG)
test demonstrated sinus arrhythmia with no abnormality
(Figure 1). Her echocardiography result was normal.
Subsequent review by a pediatric cardiologist elicited no
abnormality. Further review in the clinic determined
that her symptoms had not recurred. After discussion
with our patient and her mother, a decision was made
to not rechallenge her with ibuprofen.Correspondence: rabs01@hotmail.com
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Figure 1 An electrocardiogram performed after our patient’s symptoms had resolved demonstrates sinus arrhythmia.
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Discussion
Ibuprofen was the first non-aspirin NSAID to be
approved for over-the-counter (OTC) use, and is widely
considered to be the best tolerated drug of its class [1].
Previous studies [2,3] have demonstrated that adverse
drug reactions (ADR) to NSAIDs predominantly involve
the skin, the gastrointestinal tract, and the respiratory
system. Although it had been previously suggested that
ibuprofen may be involved in the development of ventri-
cular arrhythmia [4], only recently has ibuprofen been
demonstrated to produce arrhythmia both in vitro and
in vivo (in guinea pigs) [5]. This is achieved by a dose-
dependent shortening of the cardiac action potential
(AP), and shortening of the effective refractory period
(ERP). This had resulted in a decrease of excitation pro-
pagation within the heart, which may provide substrate
for an arrhythmogenic reentry circuit.
Cardiac arrhythmia secondary to ibuprofen overdose
has been described in the medical literature. McCune
and O’Brien reported the induction of atrial fibrillation
(AF) in a previously-well 35-year-old man [6]. Mean-
while, Menzies et al. reported a case of broad complex
tachycardia secondary to fulminant hyperkalaemia
induced by ibuprofen overdose [7]. Interestingly, Gurfin-
kel et al. [8] have found that the intravenous adminis-
tration of ibuprofen could immediately suppress
arrhythmia during a cardiac electrical storm, but this
work was conducted in the presence of decompensated
cardiopathy, a condition not shared by the our patient.
That our patient experienced only symptoms common
to those associated with the sensation of palpitations,
with no symptoms suggestive of an allergic aetiology,
suggests that this case was not one of Kounis syndrome
[9], which has recently been reported after routine ibu-
profen use [10].
Conclusion
Our patient has suffered no recurrence of her symp-
toms, and in the absence of ibuprofen rechallenge, it is
probable that standard dose ibuprofen was the causative
link with her symptoms of palpitations. No firm conclu-
sion can be drawn as to the underlying pathophysiologi-
cal mechanism of her symptoms. This case appears to
be the first case report in the medical literature of an
event adverse to cardiac arrhythmia following standard
oral ibuprofen administration.
Cardiac arrhythmia is a potentially fatal disorder that
may exhibit heart palpitations as its initial (or only)
symptom. The recognition of drug-induced cardiac dis-
turbance is necessary to prevent the progression of
symptoms to a more serious adverse event, and to avoid
reexposing patients to ibuprofen with resultant recurrent
cardiac arrhythmia. Further research is required to
identify the pathophysiological mechanism of ibuprofen-
induced cardiac arrhythmia.
Consent
Written informed consent was obtained from the
mother of our patient for publication of this case report
and any accompanying images. A copy of the written
consent is available for review by the Editor-in-Chief of
this journal.
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